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The phenotype and functional characteristics of skin-infil-
trating lymphocytes in p-Iactam antibiotic-induced vesiculo-
bullous exanthems were studied in vivo and in vitro. Im-
munohistochemical analysis demonstrated that CD8+ T 
lymphocytes were the predominant epidermal T-cell subset 
in these reactions. Epidermal T lymphocytes were isolated 
and expanded for in vitro studies. Fluorescence-activated cell 
sorter analysis showed the majority of epidermal T cells to be 
CD3+, T-cell receptor a/p+, CD4-, CD8+, and HLA-
DR+, which correlated with the predominance of epidermal 
CD8+ T lymphocytes found in situ. Three CD8+ epidermal 
T -cell clones derived from cutaneous lesions proliferated in 
response to penicillin-pulsed autologous antigen-presenting 
cells but not allogeneic antigen-presenting cells, indicating 
Bullous skin eruptions are the most severe cutaneous manifestations of drug-induced hypersensitivity reac-tions (1-4]. The drugs most frequently involved as etiologic agents are sulfonamides, anticonvulsants, and p-lactam antibiotics [3,5,6]. There is consider-
able interest in defining the pathogenetic features of these reac-
tions to improve the accuracy of methods of diagnosis and de-
velop more specific treatments. The presence of aT-cell-rich 
infiltrate in lesional skin suggests that these drug reactions may 
be T-cell mediated [7 -9]. It has been previously reported that 
peripheral blood mononuclear cells (PBMCs) from patients with 
p-lactam-induced delayed hypersensitivity reactions can be stimu-
lated in vitro by the particular drug in question [10 - 15]. In addi-
tion, two immunohistochemical studies have demonstrated that 
the inflammatory infiltrate in drug-induced toxic epidermal necrol-
ysis (TEN) is primarily composed of CD8+ T cells [16,17]. How-
ever, no studies characterizing the T-cell subsets associated with 
drug-induced blister formation have been performed. We previ-
ously generated seven CD8+ T lymphocyte clones from the pe-
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that those clOI~es were antigen and major histocompatibility 
complex specific. All T-cell clones produced significant 
amounts of interleukin-2, interferon-gamma, and granulo-
cyte-macrophage colony-stimulating factor. Additionally, 
the T-cell clones displayed cytotoxicity against epidermal 
cells in lectin-mediated cytotoxicity and against B-celilines 
in T-cell receptor-triggered cytotoxicity. These data demon-
strate the presence of epidermal drug-specific CD8+ T cells 
in bullous drug reactions. Because these CD8+ T cells have a 
cytotoxic potential, they may contribute to the necrosis of 
keratinocytes associated with drug-induced blister forma-
tion. Key words: p-Iactam antibiotics/CD8+ T lympho-
cytes/exanthems. J Invest Dermatol1 01 :794- 799, 1993 
ripheral blood of two patients with penicillin-induced maculopapu-
lar exanthems [18]. 
In the present study, we determined the phenotypic and func-
tional characteristics of lesional epidermal T lymphocytes in 
p-lactam-induced bullous exanthems. Skin sections were studied 
by immunohistochemistry using monoclonal antibodies (MoAbs) 
against various lymphocyte surface antigens. In addition, epidermal 
T cells were isolated fromp-Iactam-induced bullous eruptions and 
patch test reactions and characterized itl vitro. 
MATERIALS AND METHODS 
Patients Two p-lactam - allergic patients were studied. Patients R. W . and 
J.1. developed exanthems resembling severe erythema multiforme with 
fever, malaise, and progressive blistering 5 - 7 d after treatment with ampi-
cillin (AMPI) or benzylpenicillin (BPO), respectively. In both patients, the 
trunk and the upper extremities (30 - 40% of the total body surface) were 
primarily involved, with discrete to confluent target-like erythematous ma-
cules with central bullae. Mucous membranes were not involved. Antibodies 
immunoglobulin[Ig]M and [Ig]G against Epstein-Barr or herpes simple.:" 
viruses were not detectable. After the drug eruptions had resolved, both 
patients exhibited positive epicutaneous reactions with erythema and blis-
tering 48 h after topical application of a 5% aqueous solution of AMP! Or 
BPO, respectively. Skin biopsies were taken after informed consent at the 
time of onset of the allergic skin reaction and from a patch test reaction to 
AMPI. 
Reagents Benzylpenicillin was purchased from Hoechst (Frankfun, 
FRG), AMPI from Gruenenthal (Stolberg, FRG), phytohemagglutinin 
(PHA) from Wellcome (Burgwedel, FRG), concanavalin A (Con A) from 
Gibco Laboratories (Grand Island, NY), and OKT3 (anti-CD3) from Ortho 
Pharmaceuticals (Raritan, NJ). Recombinant human interleukin-2 (rhIL-2) 
was a generous gift from Dr. Francesco Sinigaglia, Hoffmann-La-Roche, 
Basel, Switzerland. The bispecific monoclonal antibody (MoAb) 06A (anti-
CD3xCD19) was isolated from a hybridoma fusion using OKT3 (anti-
CD3) and anti-CD19 [19]. Supernatants from hybridomas were tested in 
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Figure 1. ImmuMhist~chemical findings in an AMPI-induced bullous exanthem. CD8+ T lymphocytes (-» were stained with MoAb ~eu-2 (A). CD~+ 
cells (~) ""ere stamed WIth MoAb Leu-3a (B). HLA-DR expreSSIon (--» was determmed usmg MoAb antl-HLA-DR (e), and ICAM-llmmunoreactlVlry 
was analyzed by staining with MoAb ICAM-l (D). Staining procedures are dcscnbed m Materials and Methods. (Bars, 75 f.lm.) 
double-isotype - detecting enzyme-linkcd immunosorbcnt assays (ELISA) 
for anti-CD3 and anti-CD1 9. In addition, the function of the generated 
MoAb was determined by fluorescence-activated cell sorter (FACS) with 
CD19+jCD3- and CD3+/CD19- cells. 
Imtnunohistochemistry Skin biopsies were embedded in OCT com-
pound (Miles Scientific, Naperville, IL).using stand~d techniques. Aceton~­
fixed tissue sectIOns (8-f.lm duck) were 111cubated WIth MoAbs OKT6 (antl-
CDl) fro= Ortho, Leu-2 (anti-CD8) at 1 : 100, Leu-3a (anti-CD4) at 
1 :800, and anti-HLA-DR (1: 50) from Becton Dickinson (Oxnard, CAl, 
:mri- IL-2 receptor (CD25), and anti-CD19 at 1: 100 from Dako (Frank-
furt, FRG), anti-ICAM-l (CD 54) at 1: 50 from Dianova (Frankfurt, FRG), 
:md anti-T cell receptor (anti-TCR) alP from T Cell Sciences (Cambridge, 
MA) at 1 : 100 for 30 min. Specific-antibody binding was visualized using a 
standard alkaline phosphatase anti-alkaline phosphatase (AP AAP) technique 
according to the manufacturer's instructions (Dako). Afterwards, sections 
were counterstained with hematoxylin and mounted by routine methods. 
Culture Medium Vnless otherwise stated, cells were cultured in me-
dium that consisted of RPMI 1640 (Gibco) with 10% heat-inactivated 
fetal calf serum (Hyclone Laboratories, Logan, VT), 100 IV/ml BPO, 
100 f.lg/ml streptomycin, and 20 mM L-glutaminc (Gibco). Culture media 
for the cloning of T cells and T-cell prolifcration assays contained pooled 
human serum from AB+ donors instead of fetal calf serum and no antibio-
tics. 
Isolation of Epidermal T Cells and Generation of T-Cell 
Clones Epidermal T-cell lines from two p-lactam-allergic patients were 
established and maintained as described [20]. Punch biopsies of 4-6 mm 
were taken and were kept overnight in a 0.25% trypsin solution at 4· C. The 
epidermis was then separated from the dermis using forceps. A single-cell 
suspension was obtained by mechanical disaggregation of the epidermal 
sheet. For primary T-cell bulk cultures, epidermal cells were cultured with 
2 X 10· autologous x-irradiated (5000 R) PBMCs and appropriate concen-
trations of the antigen (AMPI 500 f.lg/ ml; BPO 1000 IV/mI) in culture 
medium. After 24 h, rhIL-2 was added at a final concentration ofl00 IV/m!' 
After 7 d, T-cell blasts were cloned by limiting dilution to 1 cell/well in 
Terasaki culture dishes in the presence of autologous PBMCs as antigen-
presenting cells (APCs) and antigen. Again, rhIL-2 (100 IV /mI) was added 
after 24 h. After 1-2 weeks, growing T-cell clones were transferred to 
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Table 1. Phenotype of Epidermal T Lymphocytes from fJ-Lactam-Induced Bullous Eruptions· 
Percent of Total Staining 
Patient Drug CD3 TCR a/ft CD4 CD8 CD19 HLA-DR CD25 
R.W. Ampici llin 
(exanthem) 100 100 25 74 0 93 8 
(patch test) 100 100 28 72 0 100 100 
J.L. Penicillin 
(exanthem) 100 100 6 90 0 99 10 
(patch test) 100 100 25 72 0 100 5 
I.T. Penicillin 
(exanthem) 100 100 12 86 0 98 94 
• FACS analysis with MoAbs 1eu-2 (anti-CDB), Leu-3a (anti-CD4), Leu-4 (ant.i-CD3), anti-CD19 , anti-:-IL-2 receptor (~1\ti-CD25), al~ti- HLA-DR, and atlti-TCR alP wer~ 
perforn1ed on T cells in bulk cultures on day 7 post-Isolatlon ftom leslonal epldenrus and subsequent sttmulatton With the particular drug, x-madtated autologous PBMCs, and IL-2. 
microtiter culture plates and maintained by repeated stimulation with PHA 
(2.5Ilg/ml) or OKT3 (1 ng/ml) using x-irradiated PBMCs as APCs [21]. 
Proliferation Assays T cells (2 - 5 X 10') were cultured with 2 X 10' 
x-irradiated (10,000 R) autologous or allogeneic B-Iymphoblastoid cell lines 
(B-LCLs) in 200-lll flat-bottom microtiter plates (Becton Dickinson, 
Lincoln Park. NJ) for 72 h at 37 °C in 5% CO2 , Prior to co-culture with 
T cells. APCs were pre incubated with tenfold concentrations of the parti-
cular drug (BPO 10.000 IV /ml; AMPI 5000 Ilg/ml) for 1 h at 37°C and 
were then extensively washed to remove unbound antigen. T-cell pro-
liferation was determined by the uptake of tritiated thymidine after 
72 h. 
Cytokine Production of Cloned T Cells Supernatants from cultures of 
PHA-stimulated epidermal T cells were obtained as described earlier (18). 
Interferon-gamma (IFN-y) . interleukin (IL)-4 and granulocyte macro-
phage-colony stimulating factor (GM-CSF) immunoreactivity in the super-
natant was determined using an enzyme-linked immunosorbent assay 
(ELISA. Genzyme. CAl. IL-2 bioactivity was analyzed using the IL-2-
sensitive human CD4+ T-cel l clone MH2 [18). 
. Cytotoxicity Assay Epidermal cells were isolated from skin specimens of 
random donors as described above. B-LCLs were established as described 
previously [21J. Epidermal cells or B-LCLs (106) were incubated in RPM I 
with 100 /1Ci ofS'Na2Cr203 (Amersham. Braunschweig. FRG) for 30 min 
at 37°C. Cells were washed thoroughly and epidermal T-cell clones were 
incubated with 10' slCr-labeled targets at different ratios (5: 1-1: 1) for 4 h 
at 3rC in 200-/11 cultures. as described [22). Alternatively, T cells were 
co-cultured with epidermal cells in the presence of Con A (2.5 /1g/ml) or 
B-LCLs in the presence of MoAb 06A (100 ng/ml). OKT3 (2 ng/ml) was 
used as a control antibody. Spontaneous 5 l Cr release did not exceed 10% ± 5 
of the total radioactivity released by treatment with detergents. slCr release 
was measured as a percentage calculated by the following formu la: 
e-c 
--X 100. 
m-c 
where e is the experimental release (T cells + targets). c is the spontaneous 
release. and m is the maximum release. 
Surface Marker Analysis T-cell clones were stained with fluorescein 
isothiocyanate (FITC)-Iabeled MoAbs OKT3 (anti-CD3), anti-TCR a/ft. 
Leu-2 (anti-CD8) . Leu-3a (anti-CD4). anti-IL-2R (anti-CD25). and anti-
HLA-DR. Cell-surface fluorescence was analyzed with a FACScan (Becton 
Dickinson). 
RESULTS 
Immunohistochemical Analysis Staining of involved skin 
from patient R.W. with AMPI-induced multiforme-like exanthem 
revealed a pattern (Fig lA - D) identical to skin sections from other 
{3-lactam- induced bullous exanthems ,(n = 5}. CD8+ T cells were 
th e predominant epidermal T-cell subset and were only, sparse in the 
upper dermis (Fig lA). CD4+ T cell s were mainly located around 
superficial dermal vessels (Fi g 1B). CD4+ cells present in the epi-
dermis were Langerhans cells (Fig IB) because they stained simulta-
neously with MoAbs Leu-3a (anti-CD4) and OKT6 (anti-CD1) 
(data not shown) . HLA-DR expression was detectable on dendritic 
cells in the epidermis and superficial dermis (Fig 1 C). Intercellular 
ad hesion molecule (ICAM)-l was expressed on basal and suprabasal 
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Figure 2. Proliferative response of epidermal CD8+ T-cell clones from 
/i-lactam - induced bullous exanthems with autologous and allogeneic B-
LCLs as APCs. T-cell clones 25El. 25E2. and 51El were incubated with. 
x-irradiated B-LCLs in 200-1l1 cultures over 72 h. Cultures were performed 
with T cells and autologous (A), or alJogeneic (B) B-LCLs alone or after 
preincubation with AMP} (LCL-AMP) or BPO (LCL-BPO). respecti~el)'. 
T-cell proliferation was determined by 3H-thYl11idine uptake after 72 h. and 
is expressed as counts per minute (cpm ± SD) for triplicate cultures. Stan-
dard deviation never exceeded 10% of the mean . 
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Pigure 3. Cyto~oxicity of epiderm.al T-cell c.lones from AMPI- and BPO-induced bullous exanthe~ns against epidermal cells and B-LCLs. T cells were 
incubated wIth 5 Cr-Iabeled freshly Isolated epIdermal ce lls or B-LCLs at a ratIo of 5 : 1 111 200-,u1 tnpltcate cultures. T cells were co-cultured with untreated 
tpidermal cells al?ne or with epidenml cells in the presence of2.5 ,ug/ml Con A .. T cells were also co-cultured with B-LCLs alone, in the presence of OKT3 
(anri-CD3), or wIth bIfunctIOnal (antI-CD3 X CD19) MoAb 06A. Spontaneous Isotope release of targets never exceeded 10% ± 5 of the maximum release. 
;'Cr release was determined as a percentage calculated by the ratio of experimental-spontaneous release and maximum-spontaneous release X 100. Standard 
dtviations never exceeded values greater than 10% of the mean. 
keratinocytes (Fig tD). In addition, CD8+ T lymphocytes were 
found attached to single keratinocytes in the blister fluid (data not 
Ihown). 
Generation ofT-Cell Clones from Bulk Cultures The ma-
jority of epidermal T cells in bulk cultures at day 7 were CD3+ 
CD8+ HLA-DR+ (Table I). Of these primary cultures, two CD8+ 
l'-cell clones were generated from patient R. W . with an AMPI-
induced multiforme-like exanthem. Additionally, four epidermal 
CD8+ T-cell clones were established from an AMPI-induced patch 
rtaction in the same patient. One CD8+ epidermal T-cell clone was 
also established from the BPO-allergic patient J.L. Selective gener-
ation of CD8+ T-cell lines as an artifact of the cloning procedure 
Was unlikely, because both CD4+ (n = S) and CD8+ (n = 2) T-
cell clones were established from a patient with a gold(I)-induced 
maculopapular exanthem (data not shown). In addition, peripheral 
CD4+ T-cell clones (n = 3) were derived from tetanus toxoid-im-
munized donors [18J . 
Imtigen-Dependent Proliferation of Epidermal T-Cell 
Clones Preliminary experiments revealed that PBMCs from 
Penicillin-allergic donors were stimulated more strongly by peni-
tiIloylated APCs, compared to cultures with soluble penicillin, dur-
ing the entire culture period (data not shown). We made an identi-
~I observation with the epidermal T cells in that the T-cell clones 
ISEl and 2SE2 did not show any significant proliferative response 
in cultures with soluble antigen (AMP I) and autologous B-LCLs as 
I\pCs (T cells + B-LCLs: 1200 ± 130 cpm; T cells + B-LCLs + 
AMpI 500/1g: 2100 ± 200 cpm). In contrast, T cells in co-culture 
With AMP I-pulsed autologous B-LCLs (LCL-AMPI) showed a sig-
nificant proliferation (Fig 2A). The T-cell clone SlEl from the 
SPO-allergic patient J.L. was also significantly stimulated in the 
presence of BPO-pulsed autologous B-LCLs (LCL-BPO) as APCs 
(Fig 2A). . 
t eeH Proliferation with Allogeneic B-LCLs as APCs The 
~oliferative responses of T-cell clones 25El and 25E2 to AMPI 
~ere completely abrogated, however, when major histocompatibil-
Ity complex (MHC) 1- and II-incompatible B-LCLs (allo[LCL] 
<\MP) were pulsed with AMPI prior to co-culture with T cells (Fig 
2B) . An identical lack of activation was observed in cultures with 
the BPO-responsive T-cell clone SlEt and BPO-labeled MHC l-
and II-incompatible B-LCLs (allo[LCLJBPO) (Fig 2B) . The MHC 
haplotypes for 2SEl and 26El were A24,2S; B44,S6; and 
DRS,w12,w8; for SlEt were A2,10; B18,40,w60; and DR4,w6; 
and for the allogeneic B-LCLs were All ,30,wt9; B37,44; and 
DR7. 
Cytotoxicity ofLesional Epidermal T-Cell Clones In stan-
dard chromiu~-release assa~s, epidermal T cells from drug-induced 
cutaneo~s leSIOns had no direct cytotoxic effect on autologous or 
allogeneic B-LCL as target cells (Fig 3A,B) . In contrast, all CD8+ 
el?idermal T~cell clones ~ere capable of T-cell receptor (TCR)-
tng~e.red lySIS o.f B cells 111 the presence of MoAb 06A (Fig 3A). 
AddltlO~1ally, epidermal T-cell clones displayed cytotoxicity against 
freshly Isolated epidermal cells in the presence of the lectin Con A 
(Fig 3B). The observed cytotoxicity required physical interaction 
between effector and target cells because supernatants from PHA-
stimulated T cells had no direct cytotoxic effect on target cells (data 
not shown). The C~4+ ~-helper-cell clone IOC from the periph-
eral blood of a patient With BPO-induced urticaria was used as a 
control . e~ector ~ell line in TCR~triggered and lectin-dependent 
cytotoxIcity . . Tlns T~cell clone displayed no cytotoxicity. T-cell 
clone 2S~1 did not d.lsplay any cytotoxicity against autologous B-
LCL prell1cubated With AMP~ (data not shown). Autologous epi-
dermal cells could not be obta1l1ed for similar experiments. 
Cytokine Production of Epidermal T Cells To determine 
whether a particular pattern of cytokines was secreted by the gener-
ated CD8+ T-cell clones, culture supernatants were harvested after 
T-cell stimulation with PHA and x-irradiated B-LCLs. All T-cell 
clones were found to produce supernatants with significant amounts 
ofIL-2 bioactivity (Fig 4A) and immunoreactive IFN-y (Fig 4B) . In 
contrast, immunoreactive IL-4 was completely absent (Fig 4C) . 
Furthermore, all T-cell clones were producers of GM-CSF (Fig 
4D). In contrast, the CD4+ T-helper-cell clone 10C produced 
significant amounts of IL-4 and rather low amounts of IFN-y. 
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Figure 4. Cytokines in supernatants from 
CD8+ epidermal T-cell clones. IL-2 bioac-
tivity is expressed as IU/ml (A) . Immuno-
reactivities of IFN-y expressed as pg/ml 
(B), ofIL-4 expressed as ng/ml (C), and of 
GM-CSF expressed as pg/ml (D), were de-
termined by ELISA as described in Materials 
and Methods. 
DISCUSSION 
We have demonstrated that CD8+ T lymphocytes are the predom-
inant epidermal T-cell population in ,8-1actam - induced bullous cu-
taneous reactions. A prevalence of epidermal CD8+ T lymphocytes 
has been previously reported by Miyauchi et af and Heng et af for 
drug-induced TEN, using identical techniques [16,17]. The drug-
induced bullous skin lesions with a lymphocyte-rich infiltrate in 
this study are clearly different from drug-induced TEN, which is 
characterized by abundant necrosis of epidermal keratinocytes but a 
rather sparse T -lymphocytic infiltrate 19,16,17]. Nevertheless, the 
observed predominance of epidermal CD8+ T lymphocytes in both 
TEN and the presented drug-induced bullous exanthems suggests 
that this particular T-cell subset plays a crucial role in the pathogen-
esis of drug-induced blister formation [9,16,1 7]. 
We have isolated exclusively CD8+ epidermal T-cell clones 
f~om ,8-lactam- induced bullous exanthems and patch-test reac-
tlOIlS. Three CD8+ T-cell clones were found to proliferate to the 
particular drug in association with a compatible MHC on the APCs. 
In a previous study, we made identical observations, in that CD8+ 
T-cell. clones .were exclusiv~ly generated from the peripheral blood 
?f patle~ts With /1-lactam-mduced maculo-papular hypersensitiv-
Ity reactions [18]. Several studies have shown that CD8+ T-cell 
lines With. cyto~oxi~ activity can mediate delayed-type inflamma-
tory reactIOns ,,'l VIVO [27,28] . In the present study, the biologic 
function of the observed MHC-unrestricted cytotoxicity against 
epidermal cells and B-LCLs is unclear because comparable data for 
drug-in.duced cytotoxicity against autologous epidermal cells are 
n.ot. available. The fact that the T-cell clone 25E1 did not kill peni-
cillin-labeled autologous B-LCLs suggests that critical molecules, 
which may be present on epidermal cells, are essential for T-cell 
cytotoxicity in vivo. In regard to the cytotoxic potential of the epi-
der~al CD8+ T -cell lines, one may speculate that they act as cyto-
tOXIC effector cells ill vivo. The assumption that epidermal CD8+ T 
cells may recognize the drug in association with MHC class I anti-
gens is stressed by a study of Claas et al [23] in which penicillins were 
~ound to intera~t with the cy.totoxic reactivity of certain HLA-typ-
mg sera and their correspond1l1g MHC class I antigens (Aw32, B 15, 
B40). CD8+ T lymphocytes have been identified as effector cells in 
al.le~gic contact dermatitis [24] , in that depletion of CD8+ T cells in 
dmmofluorobenzene (DNFB)-sensitized mice led to a substantial 
reduction in hapten-induced contact dermatitis. Kalish et al 
have also identified CD.8+ T cells as major effector cells in the peri-
c 
IOC 
rheral blood and involved skin of humans allergic to poison ivy 
l25,26] . 
All epidermal T-cell clones we~e found to ,Produce significant 
amounts of IL-2 and. IFN -yo IFN -y IS ~no:vn to 1l1duce upregulation 
ofICAM-1 on keratmocytes [30], which IS essential for T -cell bind-
ing to keratinocytes mediated by the two ligands LFA-1 and ICAM-
1 [29,32]. The interaction of lymphocyte function-associated anti-
gen 1 (LFA-1) and ICAM-1 plays a critical role in T -cell- mediated 
cytotoxicity [31] . 
. Our st~dies ?emonstra~e that .CD8+ T cells predominate in le-
slonal epidermiS from patients With ,8-lactam - induced bullous skin 
reactions. Clones derived from these lesions are CD8+ HLA-DR+ 
T cells that proliferate in response to drug-modified autologous, but 
not allogeneic, AP.Cs . .rn addition, thes~ cells produce TH 1 pattern 
cytokmes afte.r activatIOn. Further studies will be required to deter-
m1l1e the precise role that T-cell- mediated cytotoxicity plays in the 
pathogenesis of this disorder. 
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